## PH: Parker-Hannifin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.2% below STRENGTH zone (4.0-10.0%); PEG 4.89 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($847.25)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Who Owns Parker-Hannifin? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251215T130839 | Somewhat-Bullish | Relevance: 100%
- This article examines the ownership structure of Parker-Hannifin (NYSE: PH), detailing its top institutional shareholders and recent insider trading activities. It highlights that large institutional investors provide stability, while hedge funds show selective accumulation and insider trades are modest, indicating cautious investor sentiment despite the company's strong fundamentals as an industrial compounder.

**2. Corient Private Wealth LLC Sells 2,761 Shares of Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251215T100948 | Somewhat-Bullish | Relevance: 100%
- Corient Private Wealth LLC recently reduced its stake in Parker-Hannifin Corporation (NYSE:PH) by 1.2%, selling 2,761 shares and holding 0.18% of the company's stock valued at $162.5 million. Other institutional investors showed mixed activity, with some increasing and others decreasing their positions. Parker-Hannifin reported strong quarterly earnings, topping analyst estimates, and announced a quarterly dividend, while analysts maintain a "Moderate Buy" rating with an average target price of $889.50.

**3. Parker-Hannifin (PH) Stock: What to Know Before the US Market Opens on Dec. 15, 2025**
- Source: ts2.tech | 20251215T000823 | Bullish | Relevance: 100%
- Parker-Hannifin (NYSE: PH) is heading into Monday's trading session near new highs, fueled by strong aerospace demand, raised full-year guidance, and an ambitious acquisition strategy to significantly expand its filtration and aftermarket presence. Investors should be aware of the recent Filtration Group acquisition announcement, which is a major strategic catalyst, and the company's recent strong financial performance, including record quarterly sales and raised FY26 guidance. While analyst sentiment is generally bullish, the stock's valuation is no longer considered "cheap," suggesting increased sensitivity to any potential disappointments.

**4. Goldman Sachs Adjusts Parker-Hannifin Price Target to $1,000 From $900, Maintains Buy Rating**
- Source: marketscreener.com | 20251216T122249 | Bullish | Relevance: 100%
- Goldman Sachs has raised its price target for Parker-Hannifin (PH) shares to $1,000 from $900, while reaffirming a Buy rating on the stock. This adjustment reflects continued positive sentiment from analysts towards the industrial machinery and equipment company. Other firms like Jefferies and Citigroup have also recently increased their price targets for Parker-Hannifin.

**5. Andrew Ross Sells 2,488 Shares of Parker-Hannifin (NYSE:PH) Stock**
- Source: MarketBeat | 20251215T223621 | Neutral | Relevance: 100%
- Andrew Ross, COO of Parker-Hannifin (NYSE:PH), sold 2,488 shares of the company's stock for approximately $2.23 million, reducing his stake by 15.94%. The industrial products company recently reported strong quarterly earnings, surpassing analyst expectations for both EPS and revenue, and provided optimistic FY 2026 EPS guidance. Parker-Hannifin also declared a quarterly dividend and holds a "Moderate Buy" consensus rating from analysts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $1006 | $960 | +5% |
| 2025-12-04 | Barclays | $950 | $906 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Buy |
| 2025-12-04 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 4 ($2.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.1%)
- Blackrock Inc.: 7.8% (+0.6%)
- State Street Corpora: 7.6% (-0.7%)
- Procyon Advisors, LL: 4.0% (+158565.8%)
- Bank of America Corp: 3.1% (+0.6%)

### Key Risks

1. Valuation stretched: PEG 4.9x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +3.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.89 signals overvaluation risk, limited margin of safety. Forward P/E 26.7x stretched relative to 9% growth. Quality metrics strong (ROE 27%, margin 18%). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $111.8B |
| Beta | 1.25 |
| 52W Range | $488.45 - $908.35 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.89 |
| Forward P/E | 26.7 |
| Current P/E | 29.2 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.6% to 3.2% (+3.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.8pp (needs >4.0% for momentum thesis). MRS_5 at 1.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.19% (CS: 61) | Neutral |
| RSI_14 | 63.9 | Neutral |
| MACD Histogram | -0.14 | Bearish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.243x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $883.47
- **Stop Loss:** $847.25 (4.1% risk)
- **Target:** $919.69 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 33
- **Position Value:** $29,154.51
- **Portfolio %:** 29.15%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $7.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.62 | $7.22 | +9.0% |
| 2025Q2 | $7.08 | $7.69 | +8.6% |
| 2025Q1 | $6.72 | $6.94 | +3.3% |
| 2024Q4 | $6.23 | $6.53 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*